Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447))

Duerr P, Schlichtig K, Dörje F, Fromm M (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Naunyn-Schmiedeberg's Archives of Pharmacology Springer

Publisher: SPRINGER

City/Town: NEW YORK

Conference Proceedings Title: NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Event location: Stuttgart, GERMANY

Authors with CRIS profile

Katja Schlichtig Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie Frank Dörje Lehrstuhl für Pharmazeutische Technologie und Biopharmazie Martin Fromm Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie

How to cite

APA:

Duerr, P., Schlichtig, K., Dörje, F., & Fromm, M. (2019). Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447)). In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Stuttgart, GERMANY: NEW YORK: SPRINGER.

MLA:

Duerr, P., et al. "Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447))." Proceedings of the 21st Annual Meeting of the German-Society-for-Experimental-and-Clinical-Pharmacology-and-Toxicology (DGPT) / 21st Annual Meeting of the Association-of-the-Clinical-Pharmacology-Germany (VKliPha), Stuttgart, GERMANY NEW YORK: SPRINGER, 2019.

BibTeX: Download